New pathway found to enhance cancer treatment

HANOVER, NH -- Dartmouth Medical School (DMS) research points to a potentially larger role for retinoids in the treatment of cancer. The removal of a cell protein called RIP140 has significantly enhanced the cancer treatment and prevention abilities of retinoids in a laboratory setting.

Retinoids, compounds derived from Vitamin A, work by turning on proteins called retinoid receptors, which increase the abundance of a panel of retinoid "target genes." The new study, in the November 7 issue of the Journal of Biological Chemistry, builds on the prior DMS discovery that a potential retinoid receptor inhibitory protein called RIP140 is a byproduct of one of these target genes.

Now the research team has found that RIP140 is responsible for repressing the retinoid receptors, adversely affecting the ability of retinoids to differentiate cancer cells and slow tumor growth in experiments using testicular cancer cells.

"Once RIP140 was removed, growth of cancer cells was repressed by retinoids at a faster rate compared to experiments where RIP140 was present," said Kristina White, who performed the experiments with Mark Yore, both graduate students in pharmacology and toxicology. "We also noticed that anticancer genes known to be turned on by retinoids were turned on to a much greater extent," said White.

Retinoids have been known to have anti-tumor properties in the clinical setting. Based on laboratory findings, retinoids have the potential to treat and prevent a variety of leukemia and solid cancers, primarily by causing cancers to "mature" or "differentiate" and thus more closely resemble normal cells. This strategy may have less severe side-affects compared to conventional chemotherapy and may be a particularly valuable strategy in preventing cancer in high-risk individuals. However, thus far retinoids have only proven to be useful toward a small subset of cancer types in people.

"We were surprised at how much better retinoi

Contact: Andy Nordhoff
Dartmouth Medical School

Page: 1 2

Related biology news :

1. Serotonin metabolites in mollusks suggest pathways for human therapies
2. Penn scientists identify novel pathway in aneurysms
3. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
4. Activated signaling pathway may predict lung cancer patients response to gefitinib
5. A pathway to blocking autoimmunity
6. UNC scientists discover molecular pathway leading to nerve growth and regeneration
7. From lung to gut the Wnt signaling pathway transforms cell fate
8. Cell growth and death controlled by single pathway in lymphoma cancer model
9. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
10. Lock to food-borne pathogen pathway may be key to vaccine
11. Researchers uncover pathway that could lead to plant generation of human-like protein

Post Your Comments:

(Date:8/23/2020)... ... August 21, 2020 , ... The August edition ... and is now available on the company’s global website. Crystallography Times—an electronic newsletter ... presenting current news and crystallographic research. , The latest issue of Crystallography ...
(Date:8/21/2020)... CARLSBAD, Calif. (PRWEB) , ... August 19, 2020 ... ... of both Salimetrics LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for ... co-editor of the recently published book by Springer, " Salivary Bioscience: Foundations of ...
(Date:8/21/2020)... , ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial ... joined the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... the launch of a new clinical diagnostics immuno-oncology service, TissueInsight . ... (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and ...
(Date:6/28/2020)... JOSE, Calif. (PRWEB) , ... June 25, 2020 ... ... globe, researchers are racing to develop a vaccine or drug treatment. In an ... Recursion has publicly released the world’s largest imaging dataset portraying therapeutic ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... security solutions providers, today announced its strong opposition to the recently introduced bicameral ... impose a blanket ban on most federal use of nearly all biometric and ...
(Date:6/23/2020)... ... 23, 2020 , ... DeCurtis Corporation, the premier provider of ... Fournier has been appointed CEO and President. Founder and former CEO, David DeCurtis, ... “DeCurtis Corporation has been on an incredible journey for the last twenty years, ...
Breaking Biology Technology:
Cached News: